VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $590,844 | -63.2% | 63,057 | -3.7% | 0.00% | -100.0% |
| Q2 2023 | $1,606,077 | +3.0% | 65,474 | -2.3% | 0.00% | 0.0% |
| Q1 2023 | $1,559,462 | -42.4% | 67,016 | -37.3% | 0.00% | 0.0% |
| Q4 2022 | $2,707,259 | +34.1% | 106,964 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $2,019,000 | -25.0% | 104,707 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $2,691,000 | -0.5% | 105,665 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $2,704,000 | +161.8% | 105,128 | +421.7% | 0.00% | – |
| Q1 2021 | $1,033,000 | -27.9% | 20,152 | -62.3% | 0.00% | – |
| Q4 2020 | $1,432,000 | +16.7% | 53,487 | +49.6% | 0.00% | – |
| Q3 2020 | $1,227,000 | – | 35,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 22,616,666 | $284,405,000 | 3.12% |
| INDUS CAPITAL PARTNERS, LLC | 681,936 | $8,575,000 | 1.68% |
| Alphabet Inc. | 1,666,666 | $20,958,000 | 1.27% |
| Temasek Holdings (Private) Ltd | 5,499,999 | $69,162,000 | 0.45% |
| Board of Trustees of The Leland Stanford Junior University | 38,905 | $490,000 | 0.06% |
| Baillie Gifford | 500,000 | $6,287,000 | 0.01% |
| Marshall Wace North America L.P. | 74,898 | $941,000 | 0.01% |
| Capital International Investors | 983,300 | $12,365,000 | 0.00% |
| Blackstone Inc. | 35,000 | $440,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,908 | $24,000 | 0.00% |